JPMorgan reiterated its preference for domestic over Asia-exposed U.K. banks, “given the risks on US tariffs and ...

Investing.com -- President Trump’s aim to slash U.S. prescription drug prices by 50% is unlikely to materialize, according to ...

ING noted the ECB sees the recent disinflation as “mainly transitory due to energy prices and the stronger euro.” Still, ING ...

Investing.com -- Tesla (NASDAQ: TSLA) shares fell 7% following President Donald Trump’s public criticism of the company and ...

Investing.com -- Jefferies upgraded Southern Company (NYSE: SO) to Buy from Hold, citing stronger-than-expected long-term ...

Investing.com-- U.S. stocks gained on Thursday after President Trump said he had a “very good” call with Chinese President Xi ...

Huawei’s new AI compute system, CloudMatrix 384, attempts to compensate for individual chip performance by linking as many as ...

Investing.com -- Mizuho upgraded Visa Inc (NYSE: V) to Outperform from Neutral and raised its price target to $425 from $359, ...

Shares of Liminatus Pharma Inc (NASDAQ: LIMN) surged 57.3% following the company’s announcement that it has regained ...

The brokerage forecasts Dr Reddy’s semaglutide revenues at $280 million in 2027, contributing about 18% of the company’s ...

Securities said the Bank of Canada’s decision to hold its policy rate at 2.75% reflects a wait-and-see approach amid ...

Apple’s attempt to pause a lower court ruling that forces it to allow third-party payment links in its App Store was denied ...